These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction. Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139 [TBL] [Abstract][Full Text] [Related]
4. Myogenin, MyoD and IGF-I regulate muscle mass but not fiber-type conversion during resistance training in rats. Aguiar AF; Vechetti-Júnior IJ; Alves de Souza RW; Castan EP; Milanezi-Aguiar RC; Padovani CR; Carvalho RF; Silva MD Int J Sports Med; 2013 Apr; 34(4):293-301. PubMed ID: 23059557 [TBL] [Abstract][Full Text] [Related]
5. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats. Grøfte T; Wolthers T; Jensen SA; Møller N; Jørgensen JO; Tygstrup N; Orskov H; Vilstrup H Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605 [TBL] [Abstract][Full Text] [Related]
6. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Schulze PC; Gielen S; Adams V; Linke A; Möbius-Winkler S; Erbs S; Kratzsch J; Hambrecht R; Schuler G Basic Res Cardiol; 2003 Jul; 98(4):267-74. PubMed ID: 12835956 [TBL] [Abstract][Full Text] [Related]
7. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233 [TBL] [Abstract][Full Text] [Related]
9. The effect of growth hormone on rat myocardial collagen. Brüel A; Oxlund H Growth Horm IGF Res; 1999 Apr; 9(2):123-30. PubMed ID: 10373345 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone- and pressure overload-induced cardiac hypertrophy evoke different responses to ischemia-reperfusion and mechanical stretch. Strömer H; Palmieri EA; De Groot MC; Di Rella F; Leupold A; Horn M; Monti MG; Napoli R; Di Gianni A; Isgaard J; Saccà L; Neubauer S; Cittadini A Growth Horm IGF Res; 2006 Feb; 16(1):29-40. PubMed ID: 16271488 [TBL] [Abstract][Full Text] [Related]
11. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Brüel A; Christoffersen TE; Nyengaard JR Cardiovasc Res; 2007 Dec; 76(3):400-8. PubMed ID: 17673190 [TBL] [Abstract][Full Text] [Related]
13. Myogenesis and muscle metabolism in juvenile Atlantic salmon (Salmo salar) made transgenic for growth hormone. Levesque HM; Shears MA; Fletcher GL; Moon TW J Exp Biol; 2008 Jan; 211(Pt 1):128-37. PubMed ID: 18083741 [TBL] [Abstract][Full Text] [Related]
14. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [TBL] [Abstract][Full Text] [Related]
16. Role of growth hormone in chronic heart failure: therapeutic implications. Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats. Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800 [TBL] [Abstract][Full Text] [Related]
18. Myostatin and MyoD family expression in skeletal muscle of IGF-1 knockout mice. Miyake M; Hayashi S; Sato T; Taketa Y; Watanabe K; Hayashi S; Tanaka S; Ohwada S; Aso H; Yamaguchi T Cell Biol Int; 2007 Oct; 31(10):1274-9. PubMed ID: 17590360 [TBL] [Abstract][Full Text] [Related]
19. Serum insulin, IGF-I,IGF-II and growth hormone, and left ventricular mass in noninsulin-dependent mellitus. Rabkin SW; Dawson KG; Bhaumick B; O'Brein E; Kendler DL Can J Cardiol; 1996 Mar; 12(3):264-70. PubMed ID: 8624976 [TBL] [Abstract][Full Text] [Related]
20. Training improves the oxidative phenotype of muscle during the transition from cardiac hypertrophy to heart failure without altering MyoD and myogenin. Pacagnelli FL; Aguiar AF; Campos DH; Castan EP; de Souza RW; de Almeida FL; Carani F; Carvalho RF; Cicogna AC; Silva MD Exp Physiol; 2016 Aug; 101(8):1075-85. PubMed ID: 27219629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]